Vertex Pharmaceuticals, Inc. VRTX

Dividend Summary

The previous Vertex Pharmaceuticals, Inc. dividend was 0c and it went ex almost 15 years ago and it was paid almost 15 years ago.
There have not been any declared dividends recently.

Latest Dividends

Summary	Previous dividend	Next dividend
Status	Paid	–
Type	Final	–
Per share	0c	–
Declaration date	–	–
Ex-div date	31 Dec 2009 (Thu)	–
Pay date	31 Dec 2009 (Thu)	–

Enter the number of Vertex Pharmaceuticals, Inc. shares you hold and we'll calculate your dividend payments:

Previous Payment

$0.00

Paid on 31 Dec 2009 (Thu)

Next Payment

–

Forecast Accuracy

—

We have not made any dividend predictions for Vertex Pharmaceuticals, Inc.

Try Premium

Dividend Yield Today

0.0%

The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price

Free Email Notification

Add Vertex Pharmaceuticals, Inc. to receive free notifications when they declare their dividends.

Your account is set up to receive Vertex Pharmaceuticals, Inc. notifications.

Manage notifications

The table below shows the full dividend history for Vertex Pharmaceuticals, Inc.

Status	Type	Decl. date	Ex-div date	Pay date	Decl. Currency	Forecast amount	Decl. amount
Paid	Final	–	31 Dec 2009	31 Dec 2009	USD	—	0c
Paid	Final	–	31 Dec 2008	31 Dec 2008	USD	—	0c
Paid	Final	–	31 Dec 2007	31 Dec 2007	USD	—	0c
Paid	Final	–	31 Dec 2006	31 Dec 2006	USD	—	0c

Year	Amount	Change
2006	0.0c	—
2007	0.0c	 0%
2008	0.0c	 0%
2009	0.0c	 0%

Vertex Pharmaceuticals, Inc. Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.

Dividend Yield Today: 0.0%
Optimized Yield: Sign Up Required
52 Week High: 0.0% on 22 November 2023
52 Week Low: 0.0% on 22 November 2023
Next Ex-Div-Date Countdown: Sign Up Required

About Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Sector: Pharmaceuticals & Biotechnology
Country: United States
Share Price: $451.23 (yesterday's closing price)
Shares in Issue: 258 million
Market Cap: $116.2bn
CADI The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends: 0
Market Indices: NASDAQ 100, S&P 500
Investor Relations URL: Sign Up Required
Financial Calendar URL: Sign Up Required
Home Page URL: https://www.vrtx.com/

No articles found